Mauricio Rocha Dourado1,2, Eliete N S Guerra3, Tuula Salo1,2,4, Daniel W Lambert5, Ricardo D Coletta1. 1. Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba-SP, Brazil. 2. Unit of Cancer Research and Translational Medicine, Faculty of Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland. 3. Laboratory of Oral Histopathology, Health Sciences Faculty, University of Brasília, Brasília, Brazil. 4. Department of Pathology, Institute of Oral and Maxillofacial Disease, HUSLAB, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. 5. Integrated Biosciences, School of Clinical Dentistry and Sheffield Cancer Centre, University of Sheffield, Sheffield, UK.
Abstract
AIM: To perform a meta-analysis to assess whether the presence of cancer-associated fibroblasts (CAF) is a prognostic marker of oral squamous cell carcinomas (OSCC). METHODS: Immunohistochemical studies assessing the prognostic relevance of CAF (alpha smooth muscle actin (α-SMA)-positive fibroblasts) in patients with OSCC were systematically reviewed using Cochrane, Lilacs, PubMed, Scopus, and Web of Science databases. The outcomes assessed were overall survival (OS) and disease-free survival (DFS). The meta-analysis was performed using the random- and fixed-effects model with adjusted hazard ratio (HR) and 95% confidence intervals (95% CI) as effect measures. The methodological quality of the included studies was assessed using the Meta-Analysis of Statistics Assessment and Review Instrument (MAStARI) tool, and the evidence quality was assessed by the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) system. RESULTS: The presence of high levels of CAF in the stroma of OSCC predicted shortened time to DFS (HR = 3.32, 95% CI: 2.09-5.26, P < .00001) and an overall decrease in survival (HR: 2.16, 95% CI: 1.60-2.92, P < .00001). Moreover, high presence of CAF was frequently reported in association with parameters that worsen the prognosis in OSCC, including advanced disease stage (TNM classification), recurrence, tumor grade, depth of invasion, vascular, lymphatic and neural invasion, and extranodal metastatic spread. CONCLUSION: The presence of CAF, as assessed by α-SMA-positive fibroblasts in the stroma, indicates poor prognosis in patients with OSCC.
AIM: To perform a meta-analysis to assess whether the presence of cancer-associated fibroblasts (CAF) is a prognostic marker of oral squamous cell carcinomas (OSCC). METHODS: Immunohistochemical studies assessing the prognostic relevance of CAF (alpha smooth muscle actin (α-SMA)-positive fibroblasts) in patients with OSCC were systematically reviewed using Cochrane, Lilacs, PubMed, Scopus, and Web of Science databases. The outcomes assessed were overall survival (OS) and disease-free survival (DFS). The meta-analysis was performed using the random- and fixed-effects model with adjusted hazard ratio (HR) and 95% confidence intervals (95% CI) as effect measures. The methodological quality of the included studies was assessed using the Meta-Analysis of Statistics Assessment and Review Instrument (MAStARI) tool, and the evidence quality was assessed by the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) system. RESULTS: The presence of high levels of CAF in the stroma of OSCC predicted shortened time to DFS (HR = 3.32, 95% CI: 2.09-5.26, P < .00001) and an overall decrease in survival (HR: 2.16, 95% CI: 1.60-2.92, P < .00001). Moreover, high presence of CAF was frequently reported in association with parameters that worsen the prognosis in OSCC, including advanced disease stage (TNM classification), recurrence, tumor grade, depth of invasion, vascular, lymphatic and neural invasion, and extranodal metastatic spread. CONCLUSION: The presence of CAF, as assessed by α-SMA-positive fibroblasts in the stroma, indicates poor prognosis in patients with OSCC.
Authors: Miguel Ángel González-Moles; Saman Warnakulasuriya; María López-Ansio; Pablo Ramos-García Journal: Cancers (Basel) Date: 2022-08-08 Impact factor: 6.575
Authors: Alexander M Knops; Andrew South; Ulrich Rodeck; Ubaldo Martinez-Outschoorn; Larry A Harshyne; Jennifer Johnson; Adam J Luginbuhl; Joseph M Curry Journal: Front Oncol Date: 2020-11-27 Impact factor: 6.244
Authors: Alhadi Almangush; Rasheed Omobolaji Alabi; Giuseppe Troiano; Ricardo D Coletta; Tuula Salo; Matti Pirinen; Antti A Mäkitie; Ilmo Leivo Journal: BMC Cancer Date: 2021-04-30 Impact factor: 4.430
Authors: Daniel Peña-Oyarzún; Montserrat Reyes; María Paz Hernández-Cáceres; Catalina Kretschmar; Eugenia Morselli; Cesar A Ramirez-Sarmiento; Sergio Lavandero; Vicente A Torres; Alfredo Criollo Journal: Front Oncol Date: 2020-12-09 Impact factor: 6.244
Authors: Sook Ling Lai; May Leng Tan; Robert J Hollows; Max Robinson; Maha Ibrahim; Sandra Margielewska; E Kenneth Parkinson; Anand Ramanathan; Rosnah Binti Zain; Hisham Mehanna; Rachel J Spruce; Wenbin Wei; Ivy Chung; Paul G Murray; Lee Fah Yap; Ian C Paterson Journal: Cancers (Basel) Date: 2019-11-09 Impact factor: 6.639